News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
85,166 Results
Type
Article (10630)
Company Profile (6)
Press Release (74530)
Multimedia
Podcasts (59)
Webinars (1)
Section
Business (22453)
Career Advice (567)
Deals (4124)
Drug Delivery (39)
Drug Development (14482)
Employer Resources (45)
FDA (2806)
Job Trends (2603)
News (43258)
Policy (4175)
Tag
2024 Biotech Bay Standard (1)
2026 Pharm Country Premier (1)
Academia (587)
Accelerated approval (1)
Adcomms (4)
Allergies (21)
Alliances (4311)
ALS (49)
Alzheimer's disease (659)
Antibody-drug conjugate (ADC) (26)
Approvals (2788)
Artificial intelligence (40)
Autoimmune disease (8)
Automation (2)
Bankruptcy (46)
Best Places to Work (1955)
BIOSECURE Act (8)
Biosimilars (25)
Biotechnology (4)
Bladder cancer (7)
Brain cancer (6)
Breast cancer (45)
Cancer (341)
Cardiovascular disease (39)
Career advice (488)
Career pathing (10)
CAR-T (42)
Cell therapy (109)
Cervical cancer (2)
Clinical research (11689)
Collaboration (109)
Compensation (27)
Complete response letters (4)
COVID-19 (587)
CRISPR (11)
C-suite (20)
Cystic fibrosis (13)
Data (475)
Denatured (2)
Depression (15)
Diabetes (90)
Diagnostics (690)
Digital health (4)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (27)
Drug pricing (45)
Drug shortages (7)
Duchenne muscular dystrophy (38)
Earnings (12685)
Editorial (26)
Employer branding (3)
Employer resources (37)
Events (11304)
Executive appointments (75)
FDA (3028)
Featured Employer (4)
Frontotemporal dementia (4)
Funding (102)
Gene editing (19)
Generative AI (2)
Gene therapy (79)
GLP-1 (261)
Government (835)
Grass and pollen (2)
Guidances (10)
Healthcare (2548)
Huntington's disease (19)
IgA nephropathy (12)
Immunology and inflammation (31)
Indications (5)
Infectious disease (609)
Inflammatory bowel disease (12)
Inflation Reduction Act (2)
Influenza (6)
Intellectual property (15)
Interviews (119)
IPO (1991)
IRA (20)
Job creations (733)
Job search strategy (405)
Kidney cancer (3)
Labor market (15)
Layoffs (213)
Leadership (4)
Legal (735)
Liver cancer (11)
Lung cancer (48)
Lymphoma (50)
Machine learning (1)
Management (16)
Manufacturing (53)
MASH (31)
Medical device (1770)
Medtech (1771)
Mergers & acquisitions (2201)
Metabolic disorders (241)
Multiple sclerosis (32)
NASH (11)
Neurodegenerative disease (52)
Neuropsychiatric disorders (8)
Neuroscience (883)
NextGen: Class of 2025 (856)
Non-profit (780)
Northern California (389)
Now hiring (3)
Obesity (131)
Opinion (103)
Ovarian cancer (9)
Pain (21)
Pancreatic cancer (9)
Parkinson's disease (67)
Partnered (4)
Patents (41)
Patient recruitment (13)
Peanut (14)
People (4361)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase I (3082)
Phase II (5188)
Phase III (4547)
Pipeline (291)
Policy (59)
Postmarket research (518)
Preclinical (1075)
Press Release (4)
Prostate cancer (10)
Psychedelics (8)
Radiopharmaceuticals (23)
Rare diseases (86)
Real estate (472)
Recruiting (18)
Regulatory (3049)
Reports (14)
Research institute (434)
Resumes & cover letters (63)
Rett syndrome (2)
RNA editing (1)
RSV (14)
Schizophrenia (24)
Series A (18)
Series B (7)
Sickle cell disease (17)
Southern California (304)
Special edition (7)
Spinal muscular atrophy (27)
Sponsored (7)
Startups (397)
Stomach cancer (2)
Supply chain (10)
Tariffs (14)
The Weekly (55)
United States (3488)
Vaccines (148)
Venture capitalists (15)
Weight loss (119)
Women's health (9)
Worklife (8)
Date
Today (28)
Last 7 days (84)
Last 30 days (414)
Last 365 days (5376)
2025 (1594)
2024 (5601)
2023 (5864)
2022 (7522)
2021 (7920)
2020 (7578)
2019 (6116)
2018 (4586)
2017 (4282)
2016 (4279)
2015 (4947)
2014 (3519)
2013 (2574)
2012 (2836)
2011 (2893)
2010 (2351)
Location
Africa (181)
Alabama (8)
Alaska (3)
Arizona (19)
Asia (4868)
Australia (1050)
California (819)
Canada (185)
China (64)
Colorado (38)
Connecticut (29)
Delaware (34)
Europe (12559)
Florida (110)
Georgia (17)
Idaho (5)
Illinois (70)
India (5)
Indiana (58)
Japan (45)
Kansas (7)
Kentucky (1)
Louisiana (4)
Maine (35)
Maryland (107)
Massachusetts (639)
Michigan (55)
Minnesota (68)
Missouri (5)
Montana (1)
Nebraska (5)
Nevada (5)
New Hampshire (14)
New Jersey (342)
New Mexico (11)
New York (402)
North Carolina (119)
Northern California (389)
Ohio (24)
Oklahoma (1)
Oregon (6)
Pennsylvania (202)
Puerto Rico (2)
Rhode Island (8)
South America (222)
Southern California (304)
Tennessee (16)
Texas (139)
Utah (26)
Virginia (25)
Washington D.C. (23)
Washington State (89)
Wisconsin (2)
85,166 Results for "imidomics sl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
April 8, 2025
·
6 min read
Press Releases
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting
April 7, 2025
·
14 min read
Press Releases
Tonix Pharmaceuticals Announces that FDA Will Not Require an Advisory Committee Meeting to Discuss New Drug Application for TNX-102 SL for the Management of Fibromyalgia
March 25, 2025
·
13 min read
Press Releases
SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL
February 21, 2025
·
6 min read
Press Releases
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at 7th International Congress on Controversies in Fibromyalgia
March 5, 2025
·
15 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
Business
IMIDomics Establishes a License and Collaboration Partnership with the University of Barcelona to Advance Treatments for IMIDs
IMIDomics Inc. today announced a strategic license and collaboration agreement with the University of Barcelona (UB).
October 11, 2023
·
3 min read
Press Releases
Saol Therapeutics announces FDA acceptance of New Drug Application for SL1009 for treatment of Pyruvate Dehydrogenase Complex Deficiency
January 28, 2025
·
3 min read
Press Releases
IMIDomics, Inc. Appoints Life Sciences Industry Leader Matthias Evers, Ph.D., to Board of Directors
September 18, 2024
·
3 min read
Business
IMIDomics Announces Strategic Agreement with WuXi Biologics to Advance IMB1001 Antibody Development for Immune-Mediated Inflammatory Diseases
IMIDomics Inc. today announced that it has entered into an agreement with WuXi Biologics, a global Contract Research, Development and Manufacturing Organization, aimed at accelerating the development and manufacturing of IMIDomics IMB1001.
October 4, 2023
·
3 min read
1 of 8,517
Next
